Relapse of systemic lupus erythematosus [13] (multiple letters)

Lancet

Volumn 357, Issue 9258, 2001, Pages 807-808

  Rosen, Oliver ^a   Hiepe, Falk ^a   Massenkeil, Gero ^a   Thiel, Andreas ^a   Arnold, Renate ^a   Traynor, Ann ^b   Burt, Richard ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; ANTIBODY BLOOD LEVEL; CASE REPORT; CHEMOTHERAPY; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE SYSTEM; LABORATORY TEST; LETTER; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PRIORITY JOURNAL; RELAPSE; SYSTEMIC LUPUS ERYTHEMATOSUS; THERAPY;

EID: 0035836002     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)71239-3     Document Type: Letter

References (2)

1. AE Traynor J Schroeder RM Rosa Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study Lancet 356 2000 701 707
2. O Rosen A Thiel G Massenkeil Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells Arthritis Res 2 2000 327 336